Reproductive component vaccine developments for contraceptive and non-contraceptive uses

Valerie A Ferro, Deborah A Garside

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Introduction: There has been no novel contraceptive development since 'the Pill', 50 years ago. Despite the subsequent steady increase in the use of contraceptives, the contraceptive needs of a significant proportion of the world population have not yet been met. The key need is for novel, effective, practical, long-lasting, affordable, non-steroidal contraceptives. Immunocontraception, based on vaccination against components of the reproductive system that do not affect other physiological systems, fulfils most of the criteria of such a contraceptive. To date, immunocontraceptives have been developed for animal use and the application to human contraception is an exciting proposition. In addition, immunocontraceptive research has provided a greater understanding of the vaccination against 'self-antigens' and has led to non-contraceptive developments for these vaccines. Areas covered: This review provides an understanding of the historic context of immunocontraceptives and the progress that has been made. In some cases, the contraceptive aspect has been abandoned, but the knowledge gained has enabled other therapeutic advances. Expert opinion: Reproductive research is still an important area and innovations continue to arise, which offer hope for new therapeutics in reproduction and related fields.
LanguageEnglish
Pages1473-1482
Number of pages10
JournalExpert Opinion on Therapeutic Patents
Volume21
Issue number9
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Contraceptive Vaccines
Contraceptive Agents
Immunologic Contraception
Vaccination
Autoantigens
Expert Testimony
Contraception
Research
Reproduction
Vaccines
Therapeutics

Keywords

  • contraceptive vaccines
  • gametes
  • hormones
  • immunocontraception
  • immunobiology

Cite this

@article{6273d2774d214761bfdefde38958a0e7,
title = "Reproductive component vaccine developments for contraceptive and non-contraceptive uses",
abstract = "Introduction: There has been no novel contraceptive development since 'the Pill', 50 years ago. Despite the subsequent steady increase in the use of contraceptives, the contraceptive needs of a significant proportion of the world population have not yet been met. The key need is for novel, effective, practical, long-lasting, affordable, non-steroidal contraceptives. Immunocontraception, based on vaccination against components of the reproductive system that do not affect other physiological systems, fulfils most of the criteria of such a contraceptive. To date, immunocontraceptives have been developed for animal use and the application to human contraception is an exciting proposition. In addition, immunocontraceptive research has provided a greater understanding of the vaccination against 'self-antigens' and has led to non-contraceptive developments for these vaccines. Areas covered: This review provides an understanding of the historic context of immunocontraceptives and the progress that has been made. In some cases, the contraceptive aspect has been abandoned, but the knowledge gained has enabled other therapeutic advances. Expert opinion: Reproductive research is still an important area and innovations continue to arise, which offer hope for new therapeutics in reproduction and related fields.",
keywords = "contraceptive vaccines, gametes, hormones, immunocontraception, immunobiology",
author = "Ferro, {Valerie A} and Garside, {Deborah A}",
year = "2011",
month = "9",
doi = "10.1517/13543776.2011.594042",
language = "English",
volume = "21",
pages = "1473--1482",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
number = "9",

}

Reproductive component vaccine developments for contraceptive and non-contraceptive uses. / Ferro, Valerie A; Garside, Deborah A.

In: Expert Opinion on Therapeutic Patents, Vol. 21, No. 9, 09.2011, p. 1473-1482.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reproductive component vaccine developments for contraceptive and non-contraceptive uses

AU - Ferro, Valerie A

AU - Garside, Deborah A

PY - 2011/9

Y1 - 2011/9

N2 - Introduction: There has been no novel contraceptive development since 'the Pill', 50 years ago. Despite the subsequent steady increase in the use of contraceptives, the contraceptive needs of a significant proportion of the world population have not yet been met. The key need is for novel, effective, practical, long-lasting, affordable, non-steroidal contraceptives. Immunocontraception, based on vaccination against components of the reproductive system that do not affect other physiological systems, fulfils most of the criteria of such a contraceptive. To date, immunocontraceptives have been developed for animal use and the application to human contraception is an exciting proposition. In addition, immunocontraceptive research has provided a greater understanding of the vaccination against 'self-antigens' and has led to non-contraceptive developments for these vaccines. Areas covered: This review provides an understanding of the historic context of immunocontraceptives and the progress that has been made. In some cases, the contraceptive aspect has been abandoned, but the knowledge gained has enabled other therapeutic advances. Expert opinion: Reproductive research is still an important area and innovations continue to arise, which offer hope for new therapeutics in reproduction and related fields.

AB - Introduction: There has been no novel contraceptive development since 'the Pill', 50 years ago. Despite the subsequent steady increase in the use of contraceptives, the contraceptive needs of a significant proportion of the world population have not yet been met. The key need is for novel, effective, practical, long-lasting, affordable, non-steroidal contraceptives. Immunocontraception, based on vaccination against components of the reproductive system that do not affect other physiological systems, fulfils most of the criteria of such a contraceptive. To date, immunocontraceptives have been developed for animal use and the application to human contraception is an exciting proposition. In addition, immunocontraceptive research has provided a greater understanding of the vaccination against 'self-antigens' and has led to non-contraceptive developments for these vaccines. Areas covered: This review provides an understanding of the historic context of immunocontraceptives and the progress that has been made. In some cases, the contraceptive aspect has been abandoned, but the knowledge gained has enabled other therapeutic advances. Expert opinion: Reproductive research is still an important area and innovations continue to arise, which offer hope for new therapeutics in reproduction and related fields.

KW - contraceptive vaccines

KW - gametes

KW - hormones

KW - immunocontraception

KW - immunobiology

UR - http://www.scopus.com/inward/record.url?scp=80052057078&partnerID=8YFLogxK

U2 - 10.1517/13543776.2011.594042

DO - 10.1517/13543776.2011.594042

M3 - Article

VL - 21

SP - 1473

EP - 1482

JO - Expert Opinion on Therapeutic Patents

T2 - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

SN - 1354-3776

IS - 9

ER -